Merck uses deep learning tech for "beyond the pill" solutions

Amy Schofield 09 March 2017

Merck is working in partnership with Amazon Web Services (AWS) to explore the creation and delivery of innovative digital consumer solutions for people living with chronic disease.

Using Amazon Lex, the same deep learning technologies that power Amazon Alexa, Merck will initially focus on helping patients with diabetes to improve management of their own health.

Kimberly Park, vice president, Customer Strategy & Innovation, Global Human Health, Merck, said: “Merck has a deep heritage of tackling chronic diseases through our medicines, and we have been expanding into other ways to help, beyond the pill.

“We are excited to leverage the AWS Cloud to find innovative ways to leverage digital solutions, such as voice-activated technology, to help support better outcomes that could make a difference in the lives of those suffering from chronic conditions like diabetes.”

Merck is additionally sponsoring an open innovation challenge that calls on developers to create a skill for Alexa, the cloud-based voice service that powers the Amazon Echo, to help support people living with diabetes. 

Long term, Merck plans to create tools for other chronic diseases using the Amazon Lex platform and the voice-enabled Alexa system.


Make a comment

To voice your opinion, please Log in or Register.

Pf Magazine

Your resource for news, features, interviews, careers and events in the pharma industry.

Click here for the latest issue and to subscribe.